Tech Company Financing Transactions
CardioCreate Funding Round
Tech Coast Angels joined a $20 thousand funding round for CardioCreate. The financing was announced on 9/30/2013.
Transaction Overview
Company Name
Announced On
9/30/2013
Transaction Type
Venture Equity
Amount
$20,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4455 Foxhollow Ct.
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
CardioCreate is a regenerative medicine company pioneering new treatments for heart disease. Unlike conventional therapies that treat the symptoms, CardioCreate'sengineered stem cells can actually rebuild damaged heart tissue and restore cardiac function.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Flaim
Chief Scientific Officer
Mark Sussman
Co-Founder
Ned Israelsen
Browse more venture capital transactions:
Prev: 9/30/2013: Elcelyx Therapeutics venture capital transaction
Next: 9/30/2013: ShareThis venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs